Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New program aims to break the silence on palliative care for cancer patients

NCT ID NCT07402057

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a program called 'My Care My Voice' that gives cancer patients and their doctors tools like videos, brochures, and conversation cards to make it easier to talk about palliative care. The goal is to help patients bring up their care needs earlier, so they can get support for symptoms and quality of life while still receiving cancer treatment. The study involves 271 participants and will measure whether patients feel more ready to start these conversations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
My Care My Voice program (poster, training, conversation cards, video, brochure, website)
What this could lead to
If successful, this program could help cancer patients feel more comfortable starting conversations about palliative care, leading to earlier support and better quality of life.
What could go wrong
This is a small, early-stage study focused on changing behavior, not on a medical treatment. It may not show a clear benefit or be widely adopted in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 271 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria (physician): * Oncologist (medical oncologist, radiation oncologist, etc.), radiologist, organ specialist, nuclear medicine physician, ASO * The physician regularly interacts with people with advanced cancer * The physician is employed in an oncology hospital department Exclusion Criteria (physician): * The physician works mostly (\>50% of the time) in a hospital not involved in this study Inclusion Criteria (healthcare provider - potential implementer): * Healthcare provider (e.g., study coordinator, oncology coach) or another hospital staff member (e.g., administrative staff) * The implementer regularly interacts with people with advanced cancer Exclusion criteria (healthcare provider - potential implementer): \- Physician participating in My Care, My Voice Inclusion Criteria (patient): * The participant is an adult (18 years or older) * The participant has been diagnosed with advanced (i.e., non-curable) cancer (no curative treatment ongoing or planned). Participants receiving life-prolonging treatment are included. * The participant is aware of their diagnosis and treatment options as determined by their physician * The participant has known their initial diagnosis for more than one month * The participant is able to participate in a Dutch-language study * The participant is competent and able to voluntarily consent to participate in this study * The participant is hospitalized or receiving outpatient care Exclusion Criteria (patient): * Estimated survival prognosis by the physician is longer than 5 years * The participant is in a follow-up trajectory or in remission according to the physician * The participant is already receiving specialized palliative care known to the treating physician

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer neoplasm Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Groeninge

    RECRUITING

    Kortrijk, West-Flanders, 8500, Belgium

  • AZ Maria Middelares

    RECRUITING

    Ghent, East-Flanders, 9000, Belgium

  • AZorg

    RECRUITING

    Aalst, East-Flanders, 9300, Belgium

  • Ghent University Hospital

    RECRUITING

    Ghent, East-Flanders, 9000, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.